HC Wainwright & Co. Downgrades Marinus Pharma to Neutral

Benzinga · 10/25 19:48
HC Wainwright & Co. analyst Douglas Tsao downgrades Marinus Pharma (NASDAQ:MRNS) from Buy to Neutral.